By Elizabeth Renter, Natural Society, http://naturalsociety.com/big-pharma-clinical-trials-killing-thousands-india/

Large pharmaceutical companies have a need to test their new drugs on people,  and what a better place to do that with minimal risk than in a highly populated  country with little regulatory framework? That’s part of the reason Big  Pharma companies have found India to be an excellent spot for testing their  wares, using the poorest Indians as their guinea pigs for drug trials and  killing many in the process.

Recently, the Supreme Court in India took a stand, calling on the government  to justify its approval of the many clinical trials in that country. This came  as a result of several organizations campaigning for tighter regulations and  oversight on the trials.

“Clinical trials of NCEs are being conducted without following proper  protocol, and companies are taking advantage of poor people,” explained Amulya  Nidhi of the Health right Forum.

New chemical entities, or NCEs, are drugs that haven’t yet been approved for  marketing and sale, but are being tested in Phase II and Phase III clinical  trials in India. Most of these drugs, incidentally, are from Big Pharma, huge  western corporations.

Poll: 47  Million Believe Big Pharma Creates Disease

Between 2010 and 2012, 1542 deaths were reported in these clinical trials.  Officials say only 54 could be definitively linked to the trials themselves, but  either rate is too many.

So why has the Indian government allowed these corporations to come in and  test on the poorest of their countrymen? As usual, it boils down to money.

The Indian clinical trial industry was valued at $450 million in 2010-11.  It’s growing at an estimated 12% a year and predicted to pass $1 billion by  2016. The recent decision by the Indian Supreme Court, however, could derail its  trajectory.

Nidhi, and others like her, say the loss Big Pharma may suffer as a result of  the ruling and tighter regulations is inconsequential when balanced with the  safety of Indians as a whole.

“We are concerned about and committed to the interests of people,” she  said.

Better regulations could push Big Pharma trials right out of the country. A  lack of such framework is what made these corporations so comfortable,  perpetuating abuse by the “morally bankrupt pharmaceutical companies,” as Ethan  A. Huff aptly characterizes them.

Read: Drug  Companies Faked Thousands of Drug Documents

We can hope the Indian government is persuaded by the growing number of  activists there that such trials must be tightly controlled if they are to  continue. Without better controls, the corporations will continue to treat the  Indian people as throw-away laboratory experiments.

Other Popular Stories:

1. FDA: Drug Companies Faked Thousands of Drug Documents
2. India May Ban GMO Crop Field Trials for 10 Years
3. Placebo Fraud Brings Scientific Validity of Clinical Trials into  Question
4. Big Pharma to Charge 115,200 Dollars Per Patient Each Year for  New Lung Cancer Drug
5. Adverse  Drug Reactions Cover-Up? 80,000 Drug Files Go ‘Unreported’ by Big  Pharma
6. Scientists Sound Off: Ban GMO Testing In  India